Formerly the Disease Prevention and Public Health Institute, the new Institute for Translational Epidemiology aims to establish a strong program in epidemiologic research that expands on the many clinical, basic, and applied research programs within Mount Sinai and its international networks and consortia. The Institute’s vision is to advance interdisciplinary and patient-oriented research, and contributing to the overall efforts in translational research and personalized medicine at Mount Sinai.
Paolo Boffetta, MD, MPH is the Director of the Institute for Translational Epidemiology. He is Charles G. Bluhdorn Professor of International Community Medicine and Professor in the Division of Hematology and Medical Oncology and in the Department of Preventive Medicine. Read More
Mount Sinai Researcher Finds that Being One of the Younger Kids in Class May Have a Negative Effect on Academic Performance
November 19, 2012 - These findings should be taken into account before prescribing stimulants for ADHD.
Mount Sinai Researcher Finds Timing of ADHD Medication Affect Academic Progress
June 25, 2012 - Helga Zoega, PhD, Post Doctoral Fellow of Epidemiology at Mount Sinai‘s Institute for Translational Epidemiology, led the study.